Monday, 23 January 2017

Banned Antidiabetes Drugs - Phenformin, Rosiglitazone
Phenformin, an anti-diabetes drug related to metformin, was banned because it caused lactic acidosis, where it increased the pH of the blood. In more recent times, rosiglitazone has been withdrawn because of its associated risk of heart attack.
Banned Gastrointestinal Drugs - Cisapride, Tegaserod
Cisapride was a drug used in the treatment of acidity and constipation. It had the possibility of causing abnormal heart rhythms when used in high doses or when used along with other drugs like erythromycin and ketoconazole.

Tegaserod was another drug acting on the digestive system that was used to treat patients with a condition called irritable bowel syndrome with predominantly constipation. Its association with cardiovascular events like heart attack and stroke have prompted its exit.

No comments:

Post a Comment